BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wasitthankasem R, Vichaiwattana P, Auphimai C, Siripon N, Klinfueng S, Tangkijvanich P, Vongpunsawad S, Poovorawan Y. HCV core antigen is an alternative marker to HCV RNA for evaluating active HCV infection: implications for improved diagnostic option in an era of affordable DAAs. PeerJ 2017;5:e4008. [PMID: 29134150 DOI: 10.7717/peerj.4008] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
Number Citing Articles
1 Spearman CW, Sonderup MW, Dusheiko G. Authors' reply. The Lancet Gastroenterology & Hepatology 2018;3:224-5. [DOI: 10.1016/s2468-1253(18)30048-7] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
2 Wasitthankasem R, Vichaiwattana P, Siripon N, Posuwan N, Auphimai C, Klinfueng S, Thanetkongtong N, Vuthitanachot V, Saiyatha S, Thongmai C, Sochoo S, Sukthong P, Poovorawan K, Tangkijvanich P, Poovorawan Y. Birth-cohort HCV screening target in Thailand to expand and optimize the national HCV screening for public health policy. PLoS One 2018;13:e0202991. [PMID: 30138441 DOI: 10.1371/journal.pone.0202991] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
3 Wang Y, Jie W, Ling J, Yuanshuai H. HCV core antigen plays an important role in the fight against HCV as an alternative to HCV-RNA detection. J Clin Lab Anal 2021;35:e23755. [PMID: 33788295 DOI: 10.1002/jcla.23755] [Reference Citation Analysis]
4 Malsagova KA, Pleshakova TO, Galiullin RA, Shumov ID, Kozlov AF, Romanova TS, Popov VP, Glukhov AV, Konev VA, Archakov AI, Ivanov YD. Nanowire Aptamer-Sensitized Biosensor Chips with Gas Plasma-Treated Surface for the Detection of Hepatitis C Virus Core Antigen. Coatings 2020;10:753. [DOI: 10.3390/coatings10080753] [Cited by in Crossref: 13] [Cited by in F6Publishing: 1] [Article Influence: 6.5] [Reference Citation Analysis]
5 Wong XZ, Gan CC, Mohamed R, Yahya R, Ganapathy S, Tan SS, Lim SK. Hepatitis C core antigen testing to diagnose active hepatitis C infection among haemodialysis patients. BMC Nephrol 2020;21:480. [PMID: 33187498 DOI: 10.1186/s12882-020-02154-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
6 Arca-Lafuente S, Martínez-Román P, Mate-Cano I, Madrid R, Briz V. Nanotechnology: A reality for diagnosis of HCV infectious disease. J Infect 2020;80:8-15. [PMID: 31580870 DOI: 10.1016/j.jinf.2019.09.010] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 3.7] [Reference Citation Analysis]
7 Wong XZ, Amirah A, Gan CC, Fatiha S, Maznah D, Yahya R, Ganapathy S, Tan SS, Mohamed R, Lim SK. Hepatitis C virus core antigen as alternative diagnostic algorithm for active hepatitis C virus infection among haemodialysis population: Cost implications. Nephrology (Carlton) 2021;26:463-70. [PMID: 33580732 DOI: 10.1111/nep.13862] [Reference Citation Analysis]
8 Sintusek P, Thanapirom K, Komolmit P, Poovorawan Y. Eliminating viral hepatitis in children after liver transplants: How to reach the goal by 2030. World J Gastroenterol 2022; 28(3): 290-309 [DOI: 10.3748/wjg.v28.i3.290] [Reference Citation Analysis]
9 Khudur Al-Nassary MS, Mahdi BM. Study of Hepatitis C Virus Detection Assays. Ann Med Surg (Lond) 2018;36:47-50. [PMID: 30377525 DOI: 10.1016/j.amsu.2018.10.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
10 Ponnuvel S, Fletcher GJ, Anantharam R, Varughese S, David VG, Abraham P. Clinical utility of hepatitis C virus core antigen (HCVcAg) assay to identify active HCV infection in hemodialysis and renal transplant patients. PLoS One 2021;16:e0250263. [PMID: 33886631 DOI: 10.1371/journal.pone.0250263] [Reference Citation Analysis]
11 Wasitthankasem R, Vichaiwattana P, Siripon N, Posuwan N, Auphimai C, Klinfueng S, Thanetkongtong N, Vuthitanachot V, Saiyatha S, Thongmai C, Sochoo S, Pongsuwan N, Poovorawan K, Tangkijvanich P, Poovorawan Y. Liver disease burden and required treatment expenditures for hepatitis C virus (HCV) infection in Thailand: Implications for HCV elimination in the new therapeutic era, a population-based study. PLoS One 2018;13:e0196301. [PMID: 29689073 DOI: 10.1371/journal.pone.0196301] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
12 Flores GL, Mota JC, da Silva Andrade LT, Lopes RS, Bastos FI, Villar LM, Komatsu H. Performance of HCV Antigen Testing for the Diagnosis and Monitoring of Antiviral Treatment: A Systematic Review and Meta-Analysis. BioMed Research International 2022;2022:1-17. [DOI: 10.1155/2022/7348755] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Łucejko M, Tomasiewicz K, Olczak A, Tudrujek-Zdunek M, Halota W, Jelski W, Donica H, Krintus M, Mroczko B, Flisiak R. Hepatitis C virus core antigen as a possible alternative for evaluation of treatment effectiveness after treatment with direct-acting antivirals. Br J Biomed Sci 2019;76:190-4. [PMID: 31401936 DOI: 10.1080/09674845.2019.1654790] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
14 Kumbhar N, Ramachandran K, Kumar G, Rao Pasupuleti SS, Sharma MK, Gupta E. Utility of hepatitis C virus core antigen testing for diagnosis and treatment monitoring in HCV infection: A study from India. Indian J Med Microbiol 2021:S0255-0857(21)04167-0. [PMID: 34294505 DOI: 10.1016/j.ijmmb.2021.07.002] [Reference Citation Analysis]
15 Qin YJ, Sha RC, Feng YC, Huang YC. Comparison of double antigen sandwich and indirect enzyme-linked immunosorbent assay for the diagnosis of hepatitis C virus antibodies. J Clin Lab Anal 2020;34:e23481. [PMID: 33245583 DOI: 10.1002/jcla.23481] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
16 Charlton MR, Gane EJ, Shukla A, Dashtseren B, Duger D, Muljono DH, Payawal DA, Jargalsaikhan G, Purnomo HD, Cua IH, Hasan I, Sollano J Jr, Win KM, Lesmana LA, Salih M, Thi Thu Thuy P, Shankar R, Saraswat VA. International Liver Transplantation Society Asian Consensus on the Management of Hepatitis C Virus Infection in Resource Limited Setting-From Noncirrhotic to Decompensated Disease and After Liver Transplantation. Transplantation 2019;103:733-46. [PMID: 30335692 DOI: 10.1097/TP.0000000000002453] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]